← Leaderboards
Jeffrey H Teckman
Washington University
$1,054,676
Attributed
$1,054,676
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $220.5K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,054,676 · 2
By mechanism
R01$1,054,676 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- David H Perlmutter$25,711,247
- Steven D Shapiro$21,129,259
- David A Rudnick$3,126,164
- Nicholas Davidson$33,888,969
- Carl Frieden$6,868,735
Others in their field
Top investigators on “Alpha 1 Antitrypsin Deficiency”
- Edwin K Silverman · Brigham And Women'S Hospital$23,599,544
- John C Magee · University Of Michigan At Ann Arbor$19,301,456
- Robert M Merion · University Of Michigan At Ann Arbor$15,921,943
- Terence R. Flotte · University Of Florida$13,213,080
- David H Perlmutter · Washington University$10,474,681
- Ronald J Sokol · University Of Colorado Denver$9,089,729
Research focus
Alpha 1 Antitrypsin DeficiencyAlpha 1-AntitrypsinCyclosporineAlpha 1-Antitrypsin DeficiencyApoptosisAutophagocytosisAdultBiochemicalCell Culture SystemCell InjuryCellsChildChronicClinical ResearchAdoptedDesignCaspaseDrug Screening /EvaluationEndoplasmic ReticulumFatty Acid Binding ProteinFunctional DisorderFutureGenesHepatocyte
Grant awards (8)
Therapy for Alpha-1AT Deficiency Liver Disease$204,892
R01 · FY2009 · DK · contact PI
Therapy for Alpha-1AT Deficiency Liver Disease$204,892
R01 · FY2008 · DK · contact PI
Therapy for Alpha-1AT Deficiency Liver Disease$209,074
R01 · FY2007 · DK · contact PI
Therapy for Alpha-1AT Deficiency Liver Disease$215,318
R01 · FY2006 · DK · contact PI
Therapy for Alpha-1AT Deficiency Liver Disease$220,500
R01 · FY2005 · DK
4-phenylbutyrate in alpha-1-antitrypsin deficiency$0
M01 · FY2002 · RR
4-phenylbutyrate in alpha-1-antitrypsin deficiency$0
M01 · FY2001 · RR
4-phenylbutyrate in alpha-1-antitrypsin deficiency$0
M01 · FY2000 · RR